Randomized, Phase II Trial of Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery) of the Primary Tumor in Metastatic (M1) Prostate Cancer (PC)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics
- Indications Prostate cancer
- Focus Therapeutic Use
- 20 May 2019 Biomarkers information updated
- 18 Mar 2013 Planned End Date changed from 1 Apr 2018 to 1 Mar 2018 as reported by ClinicalTrials.gov.
- 11 Mar 2013 Planned end date changed from 1 Feb 2018 to 1 Apr 2018 as reported by ClinicalTrials.gov.